Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | mRNA |
Clinical data | |
Trade names | Spikevax [1] |
Routes of administration | Intramuscular |
mRNA-1283 is a COVID-19 vaccine candidate developed by Moderna. [2] [3]
An expectation, or hope seems to be that this "next generation" vaccine can be stored at regular refrigerator temperature (2-5 °C). [4]
In December, Moderna started a clinical trial which would evaluate the vaccine's ability to provoke an immune response and its safety. [5] As of September 2022, the trial is in Phase 2 [6]
An expectation, or hope seems to be that this "next generation" vaccine can be stored at regular refrigerator temperature. [4]
Development | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Classes | |||||||||||
Administration | |||||||||||
Vaccines |
| ||||||||||
Inventors/ researchers | |||||||||||
Controversy | |||||||||||
Related | |||||||||||
|
This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. |
This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |